Takeda Pharmaceutical CO LTD Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NYSE
Hillevax, Inc. has completed its merger with XRA 4 Corp., a subsidiary of XOMA Royalty Corporation, ceasing to be a publicly traded company.